Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
249 BRL | -2.26% |
|
+2.18% | +27.36% |
26/06 | Altria Submits Application for On! Plus Nicotine Pouches to FDA | DJ |
26/06 | Altria seeks FDA marketing order for oral nicotine pouch products | RE |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 8.89 and 8.74 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.36% | 7.81TCr | - | ||
-8.05% | 6.37TCr | B | ||
+19.29% | 4.83TCr | A- | ||
-1.15% | 699Cr | A- | ||
-21.79% | 497.24Cr | A- | ||
-7.50% | 235.25Cr | C- | ||
-8.73% | 217.97Cr | C- | ||
-37.96% | 147.65Cr | - | ||
-13.88% | 113.55Cr | D+ | ||
-2.34% | 99Cr | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MO Stock
- MOOO34 Stock
- Ratings Altria Group, Inc.